Company / SG&A Expense
NextCure, Inc. SG&A Expense History
FY2019-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$17.0M
FY2021
5-year range
$3.4M / $17.0M
FY2019-FY2021
Trend
+77.4%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $3M to $17M over the past 2 years.
Based on SEC 10-K filings.
$17M in FY2021.
Increased from $3M to $17M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, sg&a expense increased 77.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $17.0M | +77.4% |
| FY2020 | $9.6M | +182.0% |
| FY2019 | $3.4M | - |
As of FY2021 · SEC 10-K Annual Filings · Updated Jun 28, 2026